Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial

The Swiss Group for Clinical Cancer Research (SAKK) conducted the SAKK 35/03 randomized trial (NCT00227695) to investigate different rituximab monotherapy schedules in patients with follicular lymphoma (FL). Here, we report their long-term treatment outcome. Two-hundred and seventy FL patients were...

詳細記述

保存先:
書誌詳細
出版年:Blood Adv
主要な著者: Moccia, Alden A., Taverna, Christian, Schär, Sämi, Vanazzi, Anna, Rondeau, Stéphanie, Hitz, Felicitas, Mingrone, Walter, Pabst, Thomas, Cevreska, Lidija, del Giglio, Auro, Raats, Johann, Rauch, Daniel, Vorobiof, Daniel A., Lohri, Andreas, Ruegsegger, Céline, Biaggi Rudolf, Christine, Rusterholz, Corinne, Hayoz, Stefanie, Ghielmini, Michele, Zucca, Emanuele
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2020
主題:
Clinical Trials and Observations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724909/
https://ncbi.nlm.nih.gov/pubmed/33275769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002858
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料